Intracoronary versus intravenous administration of abciximab in patients with acute coronary syndrome: a meta-analysis.

Intracoronary versus intravenous administration of abciximab in patients with acute coronary syndrome: a meta-analysis.

BACKGROUND: Abciximab is a widely used adjunctive therapy for acute coronary syndrome (ACS). However, the effect of intracoronary (i.c.) administration of abciximab on cardiovascular events remains unclear when compared with intravenous (i.v.) therapy. METHODOLOGY AND PRINCIPAL FINDINGS: We systemat...

Full description

Bibliographic Details
Main Authors: Jie-Ning Wang, Shu Diao, Yuan-Jun Tang, An-Ji Hou, Hai-Bo Yuan, Yan Zheng, Yu-Hao Zhou
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3585408?pdf=render

Similar Items

Similar Items